ES515132A0 - "procedimiento para la determinacion de un antigeno carcinoembrionico". - Google Patents

"procedimiento para la determinacion de un antigeno carcinoembrionico".

Info

Publication number
ES515132A0
ES515132A0 ES515132A ES515132A ES515132A0 ES 515132 A0 ES515132 A0 ES 515132A0 ES 515132 A ES515132 A ES 515132A ES 515132 A ES515132 A ES 515132A ES 515132 A0 ES515132 A0 ES 515132A0
Authority
ES
Spain
Prior art keywords
carcinoembrionico
antigen
determination
procedure
antigen carcinoembrionico
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES515132A
Other languages
English (en)
Other versions
ES8400147A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES515132A0 publication Critical patent/ES515132A0/es
Publication of ES8400147A1 publication Critical patent/ES8400147A1/es
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/963—Methods of stopping an enzyme reaction or stabilizing the test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ES515132A 1981-08-21 1982-08-20 "procedimiento para la determinacion de un antigeno carcinoembrionico". Expired ES8400147A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH540381 1981-08-21
CH725881 1981-11-11

Publications (2)

Publication Number Publication Date
ES515132A0 true ES515132A0 (es) 1983-10-16
ES8400147A1 ES8400147A1 (es) 1983-10-16

Family

ID=25697628

Family Applications (1)

Application Number Title Priority Date Filing Date
ES515132A Expired ES8400147A1 (es) 1981-08-21 1982-08-20 "procedimiento para la determinacion de un antigeno carcinoembrionico".

Country Status (9)

Country Link
US (1) US4467031A (es)
EP (1) EP0072902B1 (es)
AU (1) AU554304B2 (es)
CA (1) CA1185526A (es)
DE (1) DE3263249D1 (es)
DK (1) DK158246C (es)
ES (1) ES8400147A1 (es)
FI (1) FI73322C (es)
NO (1) NO159754C (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578349A (en) * 1982-04-08 1986-03-25 Abbott Laboratories Immunoassay for carcinoembryonic antigen (CEA)
US4631254A (en) * 1982-12-06 1986-12-23 Hoffmann-La Roche Inc. Carcinoembryonic antigen determination
GB8317022D0 (en) * 1983-06-23 1983-07-27 Erba Farmitalia Adenocarcinoma related new antigenic determinants
JPS6015559A (ja) * 1983-07-06 1985-01-26 Shiraimatsu Shinyaku Kk アポリポ蛋白−ｂの酵素免疫測定試薬
EP0158291A3 (en) * 1984-04-10 1988-07-27 Takeda Chemical Industries, Ltd. A method for purifying carcinoembryonic antigen and a method for producing a carcinoembryonic antigen-reactive monoclonal antibody
US4686180A (en) * 1984-11-21 1987-08-11 South Alabama Medical Science Foundation Onco-fetal specific monoclonal antibodies, methods of preparation and use
US4873313A (en) * 1985-01-18 1989-10-10 Beckman Research Institute Of City Of Hope Specific hybridoma cell line and monocolonal antibodies produced from such specific hybridoma cell line and method of using such monoclonal antibodies to detect carcinoembryonic antigens
US4722889A (en) * 1985-04-02 1988-02-02 Leeco Diagnostics, Inc. Immunoassays using multiple monoclonal antibodies and scavenger antibodies
DE3609217A1 (de) * 1986-03-19 1987-09-24 Boehringer Mannheim Gmbh Verfahren und reagenz zur bestimmung eines reaktionspartners einer immunologischen reaktion
US4937188A (en) * 1986-04-15 1990-06-26 Northeastern University Enzyme activity amplification method for increasing assay sensitivity
US5190864A (en) * 1986-04-15 1993-03-02 Northeastern University Enzyme amplification by using free enzyme to release enzyme from an immobilized enzyme material
ES2036189T3 (es) * 1986-07-14 1993-05-16 Abbott Laboratories Un metodo para efectuar un inmunoensayo de diagnostico.
US6022958A (en) * 1986-08-13 2000-02-08 Bayer Corporation cDNAs coding for members of the carcinoembryonic antigen family
US5888728A (en) 1988-10-17 1999-03-30 Molecular Devices Corporation Hapten derivatized capture membrane and diagnostic assays using such membrane
ATE131617T1 (de) 1988-10-17 1995-12-15 Molecular Devices Corp Haptenderivatisierte aufnahmemembran und diagnostische tests, die eine solche membran verwenden
JP2619549B2 (ja) * 1989-06-29 1997-06-11 日本商事株式会社 抗原の定量法およびそれに用いる固相
US5180828A (en) * 1990-02-09 1993-01-19 Molecular Devices Corporation Chromophoric reagents for incorporation of biotin or other haptens into macromolecules
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
AU2003210274A1 (en) * 2002-02-14 2003-09-04 Schebo Biotech Aktiengesellschaft Method for the detection of tumor markers cea, ca19.9, or ca72.4 in the stool, allowing diagnosis of gastrointestinal tumors
NZ528323A (en) * 2003-09-18 2006-05-26 Horticulture & Food Res Inst Immunoassay
US20050214882A1 (en) * 2004-03-25 2005-09-29 Ez Bio Inc. Reagents, methods and kits for the universal rapid immuno-detection
US20060084184A1 (en) * 2004-10-19 2006-04-20 Renovar Incorporated Reagents for urine-based immunological assays

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1549069A (en) * 1976-12-10 1979-08-01 Erba Farmitalia Enzyme linked immunoassay
US4180556A (en) * 1977-03-09 1979-12-25 Abbott Laboratories Pretreatment method for carcinoembryonic antigen assay
JPS5510590A (en) * 1978-05-04 1980-01-25 Wellcome Found Enzyme immunity quantity analysis
US4272504A (en) * 1978-12-14 1981-06-09 Abbott Laboratories Antibody adsorbed support method for carcinoembryonic antigen assay
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
US4299815A (en) * 1980-02-08 1981-11-10 Hoffmann-La Roche Inc. Carcinoembryonic antigen determination
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4466687A (en) * 1982-05-20 1984-08-21 Amp Incorporated Low profile connector providing high density application

Also Published As

Publication number Publication date
DK373182A (da) 1983-02-22
FI822800L (fi) 1983-02-22
CA1185526A (en) 1985-04-16
NO159754B (no) 1988-10-24
NO159754C (no) 1989-02-01
US4467031A (en) 1984-08-21
DE3263249D1 (en) 1985-05-30
FI822800A0 (fi) 1982-08-11
FI73322C (fi) 1987-09-10
AU8705882A (en) 1983-05-12
NO822853L (no) 1983-02-22
ES8400147A1 (es) 1983-10-16
AU554304B2 (en) 1986-08-14
FI73322B (fi) 1987-05-29
DK158246B (da) 1990-04-16
EP0072902A1 (de) 1983-03-02
DK158246C (da) 1990-09-24
EP0072902B1 (de) 1985-04-24

Similar Documents

Publication Publication Date Title
ES515132A0 (es) "procedimiento para la determinacion de un antigeno carcinoembrionico".
ES514750A0 (es) "procedimiento para la preparacion de n-fenil-sulfonil-n'-pirimidinil- y -triacinil-ureas".
ES516368A0 (es) Procedimiento para la obtencion de fenoxifenil-azol-metilcetonas y-carbinoles.
ES511835A0 (es) "procedimiento para la preparacion de nuevas piriimidinonas".
ES515380A0 (es) "procedimiento para la preparacion de nuevos benzo-heterociclos".
ES507307A0 (es) Procedimiento para la determinacion de colesterina.
ES512914A0 (es) "procedimiento para la preparacion de nuevas fenilalcohilaminas".
ES513792A0 (es) Procedimiento para la preparacion de amidobenzamidas.
ES515377A0 (es) "un procedimiento mejorado para la preparacion de urea".
ES514505A0 (es) "procedimiento para la preparacion de 1-amino-4-hidroxi-antraquinonas".
ES515139A0 (es) Procedimiento para la obtencion de anilinometilen-oximas sustituidas.
ES513476A0 (es) Procedimiento para la obtencion de fenoxipropionatos sustituidos.
ES515751A0 (es) "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
ES514394A0 (es) "procedimiento para la preparacion de metil terci-butileter o etilterci-butileter".
ES512949A0 (es) "procedimiento para la preparacion de imidazolil-propionitrilos".
ES514106A0 (es) "procedimiento para la preparacion de hidrazonocefem-derivados".
ES511252A0 (es) "procedimiento para la preparacion de prostaglandinas".
ES517888A0 (es) Procedimiento para la preparacion de tioalcanoil-carnitinas.
ES515378A0 (es) "un procedimiento mejorado para la preparacion de urea".
ES514101A0 (es) "procedimiento para la fabricacion de etilaminas b-ciclo-substituidas".
ES510945A0 (es) "procedimiento para la preparacion de amino-pridinas".
ES512786A0 (es) Procedimiento para la obtencion de o-alquiluretanos n-monosustituidos.
ES508961A0 (es) "procedimiento para la preparacion de imidazolil-vinil-eteres".
ES520026A0 (es) Procedimiento para la obtencion de oximcarbamatos n-sulfenilados.
ES523245A0 (es) "procedimiento para la obtencion de carboximetilesteres".